RAC 0.60% $1.69 race oncology ltd

Ann: First Patient Dosed in Phase 1b/2 AML Trial, page-68

  1. 2,704 Posts.
    lightbulb Created with Sketch. 10426
    I get lots of shareholders contacting me asking about getting access to Zantrene (bisantrene) under compassionate use for their friends and family and all of the stories are terrible. The potential of Zantrene to help make a difference certainly keeps me motivated to get it back onto the market as soon as we can.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.